Mitsubishi UFJ Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.1M Sell
165,571
-248
-0.1% -$13.6K 0.01% 596
2025
Q1
$11.7M Buy
165,819
+22,674
+16% +$1.6M 0.01% 563
2024
Q4
$9.57M Buy
143,145
+16,471
+13% +$1.1M 0.01% 589
2024
Q3
$8.9M Sell
126,674
-236
-0.2% -$16.6K 0.01% 579
2024
Q2
$10.4M Buy
126,910
+20,155
+19% +$1.66M 0.01% 542
2024
Q1
$9.32M Buy
106,755
+23,156
+28% +$2.02M 0.01% 544
2023
Q4
$8.08M Sell
83,599
-317
-0.4% -$30.6K 0.01% 539
2023
Q3
$7.42M Buy
83,916
+6,768
+9% +$599K 0.02% 533
2023
Q2
$6.69M Buy
77,148
+10,928
+17% +$947K 0.01% 550
2023
Q1
$6.44M Buy
66,220
+4,512
+7% +$439K 0.02% 535
2022
Q4
$6.21M Buy
61,708
+3,934
+7% +$396K 0.02% 533
2022
Q3
$4.9M Buy
57,774
+4,271
+8% +$362K 0.02% 551
2022
Q2
$4.43M Buy
53,503
+3,832
+8% +$318K 0.02% 559
2022
Q1
$3.83M Sell
49,671
-594
-1% -$45.8K 0.02% 616
2021
Q4
$4.49M Buy
50,265
+6,749
+16% +$603K 0.02% 603
2021
Q3
$3.36M Hold
43,516
0.02% 642
2021
Q2
$3.63M Buy
43,516
+2,294
+6% +$191K 0.02% 630
2021
Q1
$3.11M Buy
41,222
+3,817
+10% +$288K 0.02% 618
2020
Q4
$3.28M Buy
37,405
+499
+1% +$43.8K 0.03% 543
2020
Q3
$2.81M Buy
36,906
+6,027
+20% +$459K 0.03% 513
2020
Q2
$3.81M Buy
30,879
+2,302
+8% +$284K 0.04% 394
2020
Q1
$2.42M Sell
28,577
-1,143
-4% -$96.6K 0.04% 417
2019
Q4
$2.5M Buy
29,720
+3,603
+14% +$303K 0.03% 480
2019
Q3
$1.76M Sell
26,117
-2,634
-9% -$178K 0.03% 488
2019
Q2
$2.46M Buy
28,751
+3,020
+12% +$259K 0.04% 394
2019
Q1
$2.29M Buy
25,731
+939
+4% +$83.4K 0.05% 366
2018
Q4
$2.09M Sell
24,792
-1,945
-7% -$164K 0.05% 324
2018
Q3
$2.59M Buy
26,737
+2,244
+9% +$218K 0.05% 342
2018
Q2
$2.31M Buy
24,493
+518
+2% +$48.8K 0.05% 355
2018
Q1
$1.94M Sell
23,975
-5,356
-18% -$434K 0.05% 394
2017
Q4
$2.7M Sell
29,331
-1,281
-4% -$118K 0.06% 322
2017
Q3
$2.85M Buy
30,612
+4,804
+19% +$447K 0.07% 298
2017
Q2
$2.34M Buy
25,808
+265
+1% +$24.1K 0.06% 337
2017
Q1
$2.24M Buy
25,543
+399
+2% +$35K 0.05% 374
2016
Q4
$2.16M Buy
25,144
+1,795
+8% +$154K 0.05% 365
2016
Q3
$2.16M Buy
23,349
+588
+3% +$54.4K 0.05% 352
2016
Q2
$1.77M Buy
22,761
+692
+3% +$53.8K 0.05% 392
2016
Q1
$1.82M Sell
22,069
-1,935
-8% -$160K 0.05% 368
2015
Q4
$2.52M Sell
24,004
-20,563
-46% -$2.15M 0.07% 267
2015
Q3
$4.69M Buy
44,567
+10,039
+29% +$1.06M 0.15% 139
2015
Q2
$4.72M Buy
34,528
+1,473
+4% +$201K 0.14% 144
2015
Q1
$4.12M Buy
33,055
+13,438
+69% +$1.67M 0.12% 176
2014
Q4
$1.81M Sell
19,617
-2,599
-12% -$240K 0.06% 362
2014
Q3
$1.6M Sell
22,216
-1,147
-5% -$82.8K 0.05% 416
2014
Q2
$1.45M Sell
23,363
-1,592
-6% -$99K 0.04% 481
2014
Q1
$1.7M Sell
24,955
-998
-4% -$68.1K 0.05% 425
2013
Q4
$1.79M Sell
25,953
-2,437
-9% -$168K 0.05% 392
2013
Q3
$2.05M Buy
28,390
+990
+4% +$71.5K 0.05% 395
2013
Q2
$1.53M Buy
+27,400
New +$1.53M 0.04% 465